Lymphocyte

Type: Product
Name: Lymphocyte
First reported 6 hours ago - Updated 34 mins ago - 1 reports

Ex-senator Musto dies

Former state Sen. Raphael John "Ray" Musto, 85, has died.Musto, who was released from a federal medical center in Butner, North Carolina, earlier this month, was suffering from lymph cell cancer.He had been in the facility for about two months after U.S. ... [Published Times News Online - 6 hours ago]
First reported 2 hours ago - Updated 2 hours ago - 2 reports

Studies from National Institute for Public Health and the Environment in the Area of Cord Blood Described

(NewsRx) -- By a News Reporter-Staff News Editor at Blood Weekly -- Current study results on Hematology have been published. According to news originating from Bilthoven, Netherlands, by NewsRx correspondents, research stated, "Leukemia incidence has ... [Published NewsRX - 2 hours ago]
First reported Apr 23 2014 - Updated 23 hours ago - 1 reports

Supplemental New Drug Application for IMBRUVICA? ibrutinib Submitted to the U.S. FDA

By a News Reporter-Staff News Editor at Biotech Week Janssen Research & Development, LLC ("Janssen") announced the submission of a supplemental New Drug Application (sNDA) for IMBRUVICA? (ibrutinib) to the U.S. Food and Drug Administration (FDA) by its ... [Published Pharmacy Choice - Apr 23 2014]
First reported Apr 23 2014 - Updated Apr 23 2014 - 1 reports

Forum Post: Re: NCRN CLL trials portfolio map

Re: NCRN CLL trials portfolio mapCLL, SLL, HCLFor people affected by CLL (chronic lymphocytic leukaemia), SLL (small lymphocytic lymphoma), or HCL (hairy cell leukaemia) to get together, ask questions, share experiences and support each other.NCRN CLL ... [Published Macmillan Cancer Support - Apr 23 2014]
First reported Apr 23 2014 - Updated Apr 23 2014 - 1 reports

Prefixation of Neutrophils for Neutrophil Antibody Testing [SCIENCE]

AbstractObjective: The granulocyte immunofluorescence test based on flow cytometry is still the most commonly used method for detecting anti-neutrophilantibodies. We questioned whether neutrophil prefixation is necessary for this test.Methods: Three pretreatment ... [Published Lab Medicine - Apr 23 2014]
First reported Apr 23 2014 - Updated Apr 23 2014 - 2 reports

Acute Lymphocytic/Lymphoblastic Leukemia Therapeutics Market - Pipeline Forecast & Market Forecast in …

/PRNewswire/ --Research and Markets  ( http://www.researchandmarkets.com/research/3mgfnj/acute ) has announced the addition of the  "Acute Lymphocytic/Lymphoblastic Leukemia Therapeutics Market - Pipeline Forecast & Market Forecast in G8 Countries (2011 ... [Published Yahoo! Finance - Apr 23 2014]
First reported Apr 23 2014 - Updated Apr 23 2014 - 1 reports

Bobbies swapping beat for saddle for charity cycle

A LEUKAEMIA sufferer has rounded up a team of cops to take part in a charity bike ride.PCSO Ray Aylott, ofThorpe le Soken is leading a 13 member group of friends, family and colleagues to raise money for Leukaemia Care by competing in the Tour de Tendring ... [Published Essex County Standard - Apr 23 2014]
First reported Apr 23 2014 - Updated Apr 23 2014 - 1 reports

New method shows how cells ward off oral diseases

Researchers at Case Western Reserve University  have found a less invasive way to extract single rare immune cells from the mouth to study how the mouth’s natural defences ward off infection and inflammation.Puspa Pandiyan, assistant professor of biological ... [Published Healthcare Learning Company - Apr 23 2014]
First reported Apr 23 2014 - Updated Apr 23 2014 - 1 reports

What makes some cancers more deadly

A Flinders University researcher is searching for answers as to why some leukaemia sufferers live a normal lifespan while others succumb to the disease within months .Dr Lauren Thurgood, based in the Department of Haematology and Genetic Pathology , is ... [Published In Daily - Apr 23 2014]
First reported Apr 22 2014 - Updated Apr 22 2014 - 1 reports

Arzerra(r) (ofatumumab) approved for the treatment of Chronic Lymphocytic

Leukemia, Diplomat to distribute04/22 06:44 CDT Leukemia, Diplomat to distribute FLINT, Mich., April 22, 2014FLINT, Mich., April 22, 2014 /PRNewswire-iReach/ -- The US Food and Drug Administration has announced the expanded approval of Arzerra(r) (ofatumumab) ... [Published Finwin - Apr 22 2014]
First reported Apr 22 2014 - Updated Apr 22 2014 - 1 reports

Insulin‐like growth factor 1 receptor signaling induced by supraphysiological doses of IGF‐1 in human peripheral blood lymphocytes

Insulin‐like growth factor‐1 (IGF‐1) mediates some of growth hormone (GH) anabolic functions through its receptor, IGF1R. Following ligand binding, intracellular signaling pathways are activated favouring proliferation, cell survival, tissue growth, development ... [Published Bionity.com - Apr 22 2014]
First reported Apr 18 2014 - Updated Apr 18 2014 - 2 reports

GlaxoSmithKline, Genmab gain FDA approval for Arzerra as first-line treatment for chronic lymphocytic leukaemia

GlaxoSmithKline and Genmab announced the FDA approval of Arzerra (ofatumumab), in combination with chlorambucil for the treatment of previously untreated patients with chronic lymphocytic leukaemia (CLL) for whom fludarabine-based therapy is considered ... [Published FirstWord Pharma - Apr 18 2014]

Quotes

...According to news originating from Bilthoven, Netherlands, by NewsRx correspondents, research stated, "Leukemia incidence has increased in recent decades among European children, -suggesting that early-life environmental exposures play an important role in disease development. We investigated the hypothesis that childhood susceptibility may increase as a result of in utero exposure to carcinogens and hormonally acting factors."
...treatment options for patients with MCD," said Frits van Rhee, University of Arkansas for Medical Sciences, and MCD2001 study lead investigator. "MCD is a complex disease and up until this point, physicians have tried to reduce lymph node masses and put the disease in remission through a combination of treatments, but MCD often returns. [Wednesday's] approval of Sylvant gives physicians a long-awaited treatment option for a group of patients who has been suffering with this chronic, serious and debilitating disease."
"Thus, for the first time, accurate detection and analysis of the type of renal cortical neoplasm may be performed on a biopsy sample obtained using non-invasive methods."

More Content

All (692) | News (589) | Reports (1) | Blogs (90) | Audio/Video (0) | Fact Sheets (0) | Press Releases (4)
sort by: Date | Relevance
Apparent resolution for Musto, Mericle comes on... [Published Wilkes-Barre Times Leader - 34 mins ago]
Studies from National Institute for Public Heal... [Published NewsRX - 2 hours ago]
Studies from D.F. Merlo et al Have Provided New... [Published NewsRX - 2 hours ago]
Detection of Circulating Tumor Cells in Hepatoc... [Published PLoS medicine - 4 hours ago]
Alkylglycerols Modulate the Proliferation and D... [Published PLoS medicine - 4 hours ago]
BD Launches Near Patient CD4 Counter System for... [Published FDA News - 5 hours ago]
The mechanism of action of BCG therapy for blad... [Published UroToday - 5 hours ago]
Ex-senator Musto dies [Published Times News Online - 6 hours ago]
FDA Approves First Castleman’s Disease Drug [Published Drug Discovery and Development - 8 hours ago]
Chemistry Seminar - Prof. Jun R. Huh, Universit... [Published University of Massachusetts Boston - 9 hours ago]
Two bits from the Disaster Information Outreach... [Published CBRNe World - 9 hours ago]
Cancer Genetics : Patent Application Titled "Pa... [Published 4 Traders - 11 hours ago]
Musto dead at 85 [Published Wilkes-Barre Times Leader - 11 hours ago]
Former state Sen. Raphael Musto dies at 85 [Published South Carolina Enquirer-Herald - 11 hours ago]
Aging is sped up in breast cancer survivors who... [Published Chemotherapy Advisor - 12 hours ago]
Former State Senator Ray Musto Dies [Published WNEP-TV 16 - 12 hours ago]
Breathe for Jo campaign closes in on £30,000 ta... [Published The Exeter Daily - 13 hours ago]
Giemsa Staining for Significant Saving: Measuri... [Published Prlog - 14 hours ago]
Siltuximab: First-Ever Drug for Castleman's Dis... [Published General Medicine eJournal - 15 hours ago]
BD Launches New Point-of-Care System for HIV/AI... [Published FinanzNachrichten.de - 15 hours ago]
Galena Biopharma Research Pioneer Presented Wit... [Published I Stock Analyst - 17 hours ago]
Galena Biopharma Research Pioneer Presented Wit... [Published BusinessWeek - 17 hours ago]
Exome sequencing [Published Multiple Sclerosis Research - 22 hours ago]
Anti-JC virus antibodies in CSF and PML [Published Multiple Sclerosis Research - 23 hours ago]
LMTK3 Deficiency Causes Pronounced Locomotor Hy... [Published Journal of Neuroscience - 23 hours ago]
Pharmacyclics to Present Phase III and Long Ter... [Published Individual.com - 23 hours ago]
Atopic dermatitis [Published Australian Doctor - Apr 24 2014]
Forum Post: Re: NCRN CLL trials portfolio map [Published Macmillan Cancer Support - Apr 23 2014]
Prefixation of Neutrophils for Neutrophil Antib... [Published Lab Medicine - Apr 23 2014]
T Cell Contamination in Flow Cytometry Gating A... [Published PLoS medicine - Apr 23 2014]
1 2 3 4 5 6 7 8 9 10 ...
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Exome sequencing [Published Multiple Sclerosis Research - 22 hours ago]
Kemppinen A, Baker A, Liao W, Fiddes B, Jones J, Compston A, Ban M, Sawcer S. Exome sequencing in single cells from the cerebrospinal fluid in multiple sclerosis.  Mult Scler. 2014 Apr. [Epub ahead of print]BACKGROUND Genome-wide association studies (GWAS) ...
Anti-JC virus antibodies in CSF and PML [Published Multiple Sclerosis Research - 23 hours ago]
Natalizumab is not 100% effective in stopping immune responses within the CNS #MSBlog #MSResearch "The following study uses a very old technique of looking for the production of specific antibodies within the central nervous system (CNS), or intrathecal ...
Acute Lymphocytic/Lymphoblastic Leukemia Therap... [Published PR Newswire: Health - Apr 23 2014]
DUBLIN, April 23, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/3mgfnj/acute) has announced the addition of the "Acute Lymphocytic/Lymphoblastic Leukemia Therapeutics Market - Pipeline Forecast & Market Forecast ...
Clinic speak: highly-effective DMTs and immuniz... [Published Multiple Sclerosis Research - Apr 23 2014]
Vaccinations on highly-effective DMTs; what you need to know. #ClinicSpeak #MSBlog #MSResearch "This study below shows that MSers treated with natalizumab mount an immune response to both a memory, or recall, vaccine (tetanus) and a new vaccine challenge ...
Gluten-free skin and beauty products: Extractin... [Published Science-Based Medicine - Apr 21 2014]
Even though yesterday was Easter, and, as unreligious as I am, I was still thinking of taking it easy, there was one target that popped up that I just couldn’t resist. My wife and I were sitting around yesterday reading the Sunday papers and perusing ...
1 2 3 4 5 6 7 8 9 10 ...

Press Releases

sort by: Date | Relevance
Lion Biotechnologies' Lead Program With Nationa... [Published GlobeNewswire: Advertising News - Apr 07 2014]
Lion Biotechnologies to Present at the 4th Annu... [Published GlobeNewswire: Acquisitions News - Mar 24 2014]
Cytocell Ltd lance une nouvelle sonde d'hématol... [Published PR Newswire - Nov 26 2013]
Health Canada Approves Genzyme's AUBAGIO® (teri... [Published PR Newswire - Nov 20 2013]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.